NantKwest, Inc. v. Merck KGaA

Good Law
United States District Court, Southern District of CaliforniaAugust 13, 20193:19-cv-01266California746 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 9 NantKest, Inc. and Brink Biologics, Inc., Case No.: 3:19-cv-1266-L-MSB

Plaintiffs,

ORDER:

v. (1) GRANTING DEFENDANTS’ Merck KGaA, Merck Serono S.p.A., and

MOTION TO FILE DOCUMENTS

EMD Serono Research & Development UNDER SEAL [Doc. 40] Institute, Inc.,

15 Defendants. (2) GRANTING PLAINTIFFS’ MOTION TO FILE OPPOSITION TO

DEFENDANTS’ MOTION TO

DISMISS AND SUPPORTING

EXHIBITS UNDER SEAL [Doc. 44]

19 Pending before the Court are Plaintiffs’ and Defendants’ motions to file portions of 20 documents under seal. On July 30, 2019, the Court granted Plaintiffs’ administrative 21 motion to file motion to enjoin and supporting exhibits under seal [Doc. 17] and Plaintiffs’ 22 administrative motion to file Complaint and supporting exhibits under seal [Doc. 19]. In 23 that order, the Court found that public disclosure of these documents might harm 24 Defendant’s competitive standing in…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.